Companies /Healthcare
Haemonetics Corp
NYSE: HAE Medical Devices
$121.11
▼ $0.61 (−0.50%) today
Markets closed · 1:08am ET

Haemonetics (HAE) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
80%
EPS beat rate
+7.20%
Avg. EPS surprise
Consecutive EPS beats
HAE vs Market · 30-day return after each reportHAES&P 500
0%+20%+40%−2.5%+2.9%Q1 26+24.9%+1.9%Q2 26−3.3%−0.1%Q3 26+44.8%+0.8%Q4 26+21.0%−0.3%Q1 27
0%+20%+40%Q1 26Q2 26Q3 26Q4 26Q1 27
HAE EPS Trend · estimate vs actualEstimateActual
$0.00$0.40$0.80$1.20$1.02$1.10Q1 26$1.11$1.27Q2 26$1.25$1.31Q3 26$1.27$1.29Q4 26
$0.00$0.40$0.80$1.20Q1 26Q2 26Q3 26Q4 26
HAE Revenue Trend · estimate vs actualEstimateActual
$0$100.0M$200.0M$300.0M$304.6M$321.4MQ1 26$311.5M$327.3MQ2 26$332.7M$339.0MQ3 26$336.9M$346.4MQ4 26
$0$100.0M$200.0M$300.0MQ1 26Q2 26Q3 26Q4 26

How Often Does Haemonetics Beat Earnings Estimates?

Haemonetics beat EPS estimates in 4 of its last 5 reported quarters, and has beaten 4 quarters in a row.

HAE quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2027 $1.14 — $339.4M —
Q4 2026 $1.29 est. $1.27 +1.38% $346.4M est. $336.9M +2.82%
Q3 2026 $1.31 est. $1.25 +4.77% $339.0M est. $332.7M +1.88%
Q2 2026 $1.27 est. $1.11 +14.34% $327.3M est. $311.5M +5.08%
Q1 2026 $1.10 est. $1.02 +8.31% $321.4M est. $304.6M +5.51%

Figures from SEC filings and company reports. Not investment advice.